Abstract

Date rape drugs (DRDs) are particularly toxic for the reason of their quick metabolism and covert administration. The detection and elimination of date rape drugs (DRDs) is crucial for preventing drug-facilitated sexual assault (DFSA). This study compares and contrasts the most current developments in identifying DRD metabolites.The present research offers an in-depth examination of analytical advancements for the identification of DRD metabolites in urine and blood samples. With an emphasis on medications such as ketamine, flunitrazepam (Rohypnol), and gamma-hydroxybutyric acid (GHB), we looked into the metabolic pathways and detection windows of these chemicals. The urine samples may not provide the same level of immediateness as blood samples when it comes to acute forensic examination, even though they offer longer detection periods because of slower metabolite excretion. On the other hand, blood samples are more accurate just after drug administration, which makes them essential for quick forensic analysis. This review research expands knowledge of DRD detection by offering a thorough evaluation of the accuracy of different analytical approaches in distinct biological matrices. It promotes the use of a dual-sample strategy to enhance forensic investigations and aid in the prosecution of DFSA cases by utilizing the advantages of both blood and urine examinations.

• 1.   Singh, Salam Bitam; Meera, Thounaojam; Singh, Thoidingjam Bijoy (May 2014);Date rape: A study on drug-facilitated sexual assaults in Imphal
• 2.   Nishtha Lahane, Gurmeet Kaur (Jan 2022);Drug facilitated sexual assault and their analysis
• 3.   Albinos Gomes(Dec 2018);Date rape drugs
• 4.   Fiona J. Couper, Laureen Marinetti (Feb 2022); Gamma-hydroxybutyrate (GHB) – Effects on human performance and behaviour
• 5.   Alan D. Brailsford, David A. Cowan, Andrew T. Kicman(Mar 2012); Pharmacokinetic properties of gamma-hydroxybutyrate(GHB) in whole blood, serum and urine
• 6.   Stanley F. Malamed DDS (2010); Pharmacology in Sedation (Fifth edition)
• 7.   Matthew D. Krasowski (2019); Drug-assisted sexual assaults in Critical Issues in Alcohol and Drugs of Abuse Testing (Second edition)
• 8.   Zahra Nikfarjam, Ronald W. Brown (2022); Pharmaceutical applications of 1,4-benzodiazepinesin Benzodiazepine-Based Drug Discovery
• 9.   Jens-Uwe Peter, Peter Dieudonne, Oliver Zolk (Apr 2024); Pharmacokinetics, Pharmacodynamics, and side effects of Midazolam: A review and case example
• 10.   Craig W. Stevens (2020); Death Be Not Proud: The pharmacology of lethal drug executions in The Drug Expert
• 11.   David J. Hanson (2013); The effects of substances on driving in Principles of Addiction
• 12.   Kenneth C. Jackson II, Charles E. Argoff (2008); Skeletal muscle relexants in Raj’s Practical Management of Pain (Fourth edition)
• 13.   Alan Carter, Joseph Nordqvist(Jan 2024);The benefits and risks of Benzodiazepines
• 14.   Steven L. Dubovsky, Dori Marshall (Aug 2022); Benzodiazepines remain important therapeutic options in psychiatric practice
• 15.   Hajira Basit, Chadi I. Kahwaji (May 2013); Clonazepam
• 16.   Tobin T. George, Jayson Tripp. (Apr 2023); Alprazolam
• 17.   Zahra Nikfarjam, Ronald W. Brown (2022); Pharmaceutical applications of 1,4-benzodiazepines in Benzodiazepine-Based drug discovery
• 18.   Bethesda (Jun 2023); Flurazepam
• 19.   G. E.Pakes, R. N. Brogden, R. C. Heel, T. M. Speight, G.S. Avery (Aug 1981): Triazolam: A reviewof its pharmacological properties and therapeutic efficacy in patients with insomnia
• 20.   Charles E. Griffin III, Adam M. Kaye, Franklin Rivera Bueno, Alan D. Kaye(2013); Benzodiazepine pharmacology and central nervous system- mediated effects
• 21.   Elisabet Batlle Rocafort (2018); Benzodiazepines and derivatives: overview, analysis and synthesis
• 22.   Ricardo Jorge Dinis-Oliveira (Feb 2017); Metabolism and metabolomics of ketamine: A toxicological approach
• 23.   Rishi Pal, Anil Kumar Teotia (Apr 2010);Date rape drugs and their forensic analysis: An update
• 24.   Alba m. Rodrigo Valero, Oscar Quintela Jorge, Begona BravoSerrano and Sara Ayuso Tejedor (Nov 2023);Optimization of a rapid method for screening drugs in blood by liquid chromatography tandem mass spectrometry
• 25.   Christina Ververi, Marco Vincenti, AlbertoSalomone (Nov 2022);Recent advances in the detection of drugs of abuse by dried blood spots
• 26.   Agnieszka Niemiec(Sep 2021);Dried blood spot in toxicology: Current knowledge
• 27.   Toyoshi Umezu (Jan 2013);The use of dried blood spot samples in screening drugs of abuse
• 28.   Magdalena Swiadro, Pawet Stelmaszczyk, Renata Wietecha, Dominika Dudek (Nov 2020);Development of a new method for drug detection based on a combination of the dried blood spot method and capillary electrophoresis
• 29.   Scott e. Hadland, Sharon Levy (Mar 2016);Objective testing- Urine and other drug tests
• 30.   Shin-Yu Lin, Hei-Hwa Lee, Jong-Feng Lee, Bai HsiunChen (Jan 2018);Urine specimen validity test for drug abuse testing in workplace and court settings
• 31.   Debra Stang (Sep 2018);Understanding the urine drug test
• 32.   J. Lakshmi Charan, KSita Manikyam (Mar 2023);Forensic science and its limitations in rape and murder cases in india
• 33.   Chanbasha Basheer (Aug2011);Recent analytical strategies on “date-rape” drugs and its metabolites
• 34.   Emily A. Walsh, Dr. Virginia M. Maxwell; The detection of date rape drug residues using X-ray diffraction
• 35.   K. Skov, S.S. Johansen, K. Linnet, M.K. K.Nielsen; A review on the forensic toxicology of global drug-facilitated sexual assaults
• 36.   Swaroop S. Ssonone, Swapnanil Jadhav, Mahipal Singh Sankhla (Aug 2021); A forensic aspect on drug facilitated sexual assault
• 37.   Nancy Findholt, Linda C. Robrecht (Sept 2002); Legal and ethical considerations in research with sexually active adolescents: the requirement to report statutory rape.
• 38.   Jagadeesh N., Padma Bhatedeosthali, Sangeeta Rege (Nov 2016);Ethical concerns related to mandatory reporting of sexual violence.

Data Sharing Statement

Funding